maltol has been researched along with deferiprone in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Arthur, HM; Brock, JH; Kontoghiorghes, GJ; Licéaga, J | 1 |
| Chambers, S; Hoffbrand, AV; Kontoghiorghes, GJ | 1 |
| Kontoghiorghes, GJ | 2 |
| el-Jammal, A; Templeton, DM | 1 |
| Costa Pessoa, J; Enyedy, EA; González, CS; Hollender, D; Jakusch, T; Kiss, T; Montes-Bayón, M; Sanz-Medel, A; Tomaz, I | 1 |
| Canário, S; Carrasco, MP; Chaves, S; Mira, L; Santos, MA | 1 |
1 review(s) available for maltol and deferiprone
| Article | Year |
|---|---|
Deferiprone and Iron-Maltol: Forty Years since Their Discovery and Insights into Their Drug Design, Development, Clinical Use and Future Prospects.
Topics: Deferiprone; Drug Design; Humans; Iron; Iron Chelating Agents; Iron Overload; Pyridones | 2023 |
7 other study(ies) available for maltol and deferiprone
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Effect of novel 1-alkyl-3-hydroxy-2-methylpyrid-4-one chelators on uptake and release of iron from macrophages.
Topics: Animals; Deferiprone; Deferoxamine; Iron; Iron Chelating Agents; Iron Radioisotopes; Macrophages; Mice; Mimosine; Pyridones; Pyrones | 1990 |
Comparative study of iron mobilization from haemosiderin, ferritin and iron(III) precipitates by chelators.
Topics: Deferiprone; Ferritins; Hemosiderin; Iron; Iron Chelating Agents; Mimosine; Pyridines; Pyridones; Pyrones | 1987 |
Iron mobilization from ferritin using alpha-oxohydroxy heteroaromatic chelators.
Topics: Chelating Agents; Deferiprone; Deferoxamine; Dialysis; Ferritins; Iron; Ketones; Pyridones; Pyrones; Spectrophotometry | 1986 |
Reversed-phase high-performance liquid chromatography of non-transferrin-bound iron and some hydroxypyridone and hydroxypyrone chelators.
Topics: Chromatography, High Pressure Liquid; Deferiprone; Humans; Hydrogen-Ion Concentration; Iron; Iron Chelating Agents; Pyridones; Pyrones; Sensitivity and Specificity | 1994 |
Biospeciation of various antidiabetic V(IV)O compounds in serum.
Topics: Apoproteins; Chromatography, High Pressure Liquid; Deferiprone; Humans; Hypoglycemic Agents; Mass Spectrometry; Molecular Structure; Organometallic Compounds; Pyridones; Pyrones; Serum Albumin; Thermodynamics; Time Factors; Transferrin; Ultrafiltration; Vanadium | 2009 |
Hydroxy(thio)pyrone and hydroxy(thio)pyridinone iron chelators: physico-chemical properties and anti-oxidant activity.
Topics: Antioxidants; Coordination Complexes; Deferiprone; Electrochemical Techniques; Iron; Iron Chelating Agents; Kinetics; Lipid Peroxidation; Oxidation-Reduction; Pyridones; Pyrones | 2012 |